4th Quarter - Report

WASHINGTON STRATEGIC CONSULTING for ATLANTICARE

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Alternatives to Opioids (ALTO) Demonstration program funding, Resident Physician Shortage Act of 2019 S. 348) - Increased funding for Medicare GME slots, Surprise Medical Bills (pending legislation), Medicaid DSH cuts, Improving Access to Medicare Coverage Act (H.R. 1682/S. 753) - Addressing the Medicare 3-Day Rule for nursing home care, Home Health Payment Innovation Act (S. 433) - Limit Medicare rate changes to 2 percent per year, Protecting Jessica Grubbs Legacy Act (S. 1012) - Federal privacy rules (42 CFR Part 2), Overdose Prevention and Patient Safety Act (H.R. 2062) - Federal privacy rules (42 CFR Part 2), Palliative Care and Hospice Education Act, Protecting Pre-Existing Conditions & Making Health Care More Affordable Act, State Allowance for a Variety of Exchanges (SAVE) Act (H.R. 1385), Pandemic All-Hazards legislation, Medicare area wage index

LobbyistCovered position, as disclosed
KYLE T MULROY Legislative Assistant, former Sen. Torricelli

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1682 (116th), H.R. 2062 (116th), S. 753 (116th), H.R. 1385 (116th), S. 1012 (116th), S. 348 (116th), S. 433 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.